

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NADH metabolic process (GO:0006734) | 4.58163840 |
| 2 | proteasome assembly (GO:0043248) | 4.57739446 |
| 3 | nuclear pore complex assembly (GO:0051292) | 4.47737692 |
| 4 | lysine metabolic process (GO:0006553) | 4.43800218 |
| 5 | lysine catabolic process (GO:0006554) | 4.43800218 |
| 6 | serine family amino acid catabolic process (GO:0009071) | 4.35723134 |
| 7 | tricarboxylic acid cycle (GO:0006099) | 4.31843932 |
| 8 | biotin metabolic process (GO:0006768) | 4.30632853 |
| 9 | purine nucleobase biosynthetic process (GO:0009113) | 4.27645939 |
| 10 | 2-oxoglutarate metabolic process (GO:0006103) | 4.26938939 |
| 11 | glycine metabolic process (GO:0006544) | 4.22647926 |
| 12 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 4.20660316 |
| 13 | cellular ketone body metabolic process (GO:0046950) | 4.10499176 |
| 14 | pseudouridine synthesis (GO:0001522) | 4.06368351 |
| 15 | formation of translation preinitiation complex (GO:0001731) | 4.05679469 |
| 16 | nuclear pore organization (GO:0006999) | 4.02820067 |
| 17 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.00733156 |
| 18 | L-phenylalanine catabolic process (GO:0006559) | 4.00733156 |
| 19 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.99007974 |
| 20 | CENP-A containing nucleosome assembly (GO:0034080) | 3.98685745 |
| 21 | valine metabolic process (GO:0006573) | 3.94827823 |
| 22 | cysteine metabolic process (GO:0006534) | 3.93677648 |
| 23 | folic acid-containing compound biosynthetic process (GO:0009396) | 3.92193164 |
| 24 | establishment of integrated proviral latency (GO:0075713) | 3.92024096 |
| 25 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 3.91456556 |
| 26 | L-phenylalanine metabolic process (GO:0006558) | 3.88593650 |
| 27 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.88593650 |
| 28 | nucleobase biosynthetic process (GO:0046112) | 3.86767474 |
| 29 | ribosomal large subunit biogenesis (GO:0042273) | 3.84034854 |
| 30 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.83738586 |
| 31 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 3.81420794 |
| 32 | chromatin remodeling at centromere (GO:0031055) | 3.81386286 |
| 33 | branched-chain amino acid catabolic process (GO:0009083) | 3.80355077 |
| 34 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 3.77926305 |
| 35 | IMP biosynthetic process (GO:0006188) | 3.77826540 |
| 36 | aromatic amino acid family catabolic process (GO:0009074) | 3.74612953 |
| 37 | carnitine shuttle (GO:0006853) | 3.73201992 |
| 38 | amino-acid betaine metabolic process (GO:0006577) | 3.68909554 |
| 39 | tryptophan catabolic process (GO:0006569) | 3.67339965 |
| 40 | indole-containing compound catabolic process (GO:0042436) | 3.67339965 |
| 41 | indolalkylamine catabolic process (GO:0046218) | 3.67339965 |
| 42 | fatty acid beta-oxidation (GO:0006635) | 3.66061740 |
| 43 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 3.65391267 |
| 44 | negative regulation of ligase activity (GO:0051352) | 3.65391267 |
| 45 | serine family amino acid metabolic process (GO:0009069) | 3.65335813 |
| 46 | kynurenine metabolic process (GO:0070189) | 3.63162324 |
| 47 | fatty acid transmembrane transport (GO:1902001) | 3.61770319 |
| 48 | * rRNA modification (GO:0000154) | 3.60420194 |
| 49 | tryptophan metabolic process (GO:0006568) | 3.58776348 |
| 50 | IMP metabolic process (GO:0046040) | 3.55326811 |
| 51 | sulfur amino acid catabolic process (GO:0000098) | 3.54742226 |
| 52 | glyoxylate metabolic process (GO:0046487) | 3.54359968 |
| 53 | tRNA aminoacylation for protein translation (GO:0006418) | 3.54143587 |
| 54 | DNA strand elongation involved in DNA replication (GO:0006271) | 3.53173107 |
| 55 | folic acid metabolic process (GO:0046655) | 3.50860096 |
| 56 | mitotic metaphase plate congression (GO:0007080) | 3.50434783 |
| 57 | regulation of cofactor metabolic process (GO:0051193) | 3.50341407 |
| 58 | regulation of coenzyme metabolic process (GO:0051196) | 3.50341407 |
| 59 | branched-chain amino acid metabolic process (GO:0009081) | 3.49988585 |
| 60 | tRNA aminoacylation (GO:0043039) | 3.48402120 |
| 61 | amino acid activation (GO:0043038) | 3.48402120 |
| 62 | ketone body metabolic process (GO:1902224) | 3.46886180 |
| 63 | ribonucleoprotein complex biogenesis (GO:0022613) | 3.46688771 |
| 64 | vitamin transmembrane transport (GO:0035461) | 3.46300486 |
| 65 | cullin deneddylation (GO:0010388) | 3.43187630 |
| 66 | establishment of viral latency (GO:0019043) | 3.42891179 |
| 67 | DNA strand elongation (GO:0022616) | 3.42208508 |
| 68 | DNA replication checkpoint (GO:0000076) | 3.39596371 |
| 69 | fatty acid oxidation (GO:0019395) | 3.37942199 |
| 70 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 3.37551910 |
| 71 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.37131099 |
| 72 | serine family amino acid biosynthetic process (GO:0009070) | 3.36844836 |
| 73 | pore complex assembly (GO:0046931) | 3.34547680 |
| 74 | homocysteine metabolic process (GO:0050667) | 3.34091376 |
| 75 | * rRNA processing (GO:0006364) | 3.32289549 |
| 76 | histone exchange (GO:0043486) | 3.32231074 |
| 77 | protein deneddylation (GO:0000338) | 3.32212987 |
| 78 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 3.32062732 |
| 79 | maturation of 5.8S rRNA (GO:0000460) | 3.31384019 |
| 80 | pteridine-containing compound biosynthetic process (GO:0042559) | 3.31140728 |
| 81 | positive regulation of ligase activity (GO:0051351) | 3.29534909 |
| 82 | regulation of cellular amino acid metabolic process (GO:0006521) | 3.28698094 |
| 83 | quinone biosynthetic process (GO:1901663) | 3.28558731 |
| 84 | ubiquinone biosynthetic process (GO:0006744) | 3.28558731 |
| 85 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.28469864 |
| 86 | lipid oxidation (GO:0034440) | 3.28005961 |
| 87 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 3.27909682 |
| 88 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 3.27909682 |
| 89 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 3.27909682 |
| 90 | DNA replication-independent nucleosome organization (GO:0034724) | 3.27830924 |
| 91 | DNA replication-independent nucleosome assembly (GO:0006336) | 3.27830924 |
| 92 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 3.27536809 |
| 93 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 3.27449942 |
| 94 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 3.27449942 |
| 95 | carnitine metabolic process (GO:0009437) | 3.25954262 |
| 96 | * mitochondrial RNA metabolic process (GO:0000959) | 3.25867726 |
| 97 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 3.22990316 |
| 98 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 3.22990316 |
| 99 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 3.22775366 |
| 100 | termination of RNA polymerase III transcription (GO:0006386) | 3.22775366 |
| 101 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.22662095 |
| 102 | oxaloacetate metabolic process (GO:0006107) | 3.22117786 |
| 103 | protein targeting to mitochondrion (GO:0006626) | 3.20065194 |
| 104 | urate metabolic process (GO:0046415) | 3.18519092 |
| 105 | regulation of attachment of spindle microtubules to kinetochore (GO:0051988) | 3.18298334 |
| 106 | short-chain fatty acid metabolic process (GO:0046459) | 3.16881591 |
| 107 | * rRNA metabolic process (GO:0016072) | 3.16852181 |
| 108 | transcription elongation from RNA polymerase I promoter (GO:0006362) | 3.15641537 |
| 109 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 3.14930224 |
| 110 | mitotic nuclear envelope disassembly (GO:0007077) | 3.14519478 |
| 111 | regulation of ubiquitin-protein transferase activity (GO:0051438) | 3.14453865 |
| 112 | fatty acid catabolic process (GO:0009062) | 3.13456052 |
| 113 | alpha-amino acid catabolic process (GO:1901606) | 3.13104028 |
| 114 | double-strand break repair via nonhomologous end joining (GO:0006303) | 3.12420463 |
| 115 | non-recombinational repair (GO:0000726) | 3.12420463 |
| 116 | chaperone-mediated protein transport (GO:0072321) | 3.09908176 |
| 117 | regulation of sequestering of triglyceride (GO:0010889) | 3.09815590 |
| 118 | termination of RNA polymerase I transcription (GO:0006363) | 3.08941480 |
| 119 | regulation of mitotic spindle checkpoint (GO:1903504) | 3.08829175 |
| 120 | regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266) | 3.08829175 |
| 121 | regulation of ligase activity (GO:0051340) | 3.08715016 |
| 122 | G1/S transition of mitotic cell cycle (GO:0000082) | 3.07544766 |
| 123 | cell cycle G1/S phase transition (GO:0044843) | 3.07544766 |
| 124 | * rRNA methylation (GO:0031167) | 3.07116082 |
| 125 | tricarboxylic acid metabolic process (GO:0072350) | 3.06428617 |
| 126 | succinate metabolic process (GO:0006105) | 3.06065454 |
| 127 | * transcription from mitochondrial promoter (GO:0006390) | 3.04668498 |
| 128 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 3.00632683 |
| 129 | spliceosomal snRNP assembly (GO:0000387) | 3.00221474 |
| 130 | cellular amino acid catabolic process (GO:0009063) | 2.99873529 |
| 131 | protein localization to kinetochore (GO:0034501) | 2.99843465 |
| 132 | bile acid biosynthetic process (GO:0006699) | 2.99680062 |
| 133 | histone mRNA metabolic process (GO:0008334) | 2.99219326 |
| 134 | telomere maintenance via recombination (GO:0000722) | 2.98758858 |
| 135 | regulation of translational fidelity (GO:0006450) | 2.98694506 |
| 136 | DNA replication-dependent nucleosome organization (GO:0034723) | 2.97536148 |
| 137 | DNA replication-dependent nucleosome assembly (GO:0006335) | 2.97536148 |
| 138 | protein localization to chromosome, centromeric region (GO:0071459) | 2.97037652 |
| 139 | aspartate family amino acid catabolic process (GO:0009068) | 2.96873343 |
| 140 | cellular component biogenesis (GO:0044085) | 2.96767460 |
| 141 | aromatic amino acid family metabolic process (GO:0009072) | 2.96524989 |
| 142 | DNA damage response, detection of DNA damage (GO:0042769) | 2.94611181 |
| 143 | regulation of sulfur metabolic process (GO:0042762) | 2.94562472 |
| 144 | regulation of mitochondrial translation (GO:0070129) | 2.93981904 |
| 145 | ribosome biogenesis (GO:0042254) | 2.93443694 |
| 146 | mitotic recombination (GO:0006312) | 2.93408471 |
| 147 | DNA catabolic process, exonucleolytic (GO:0000738) | 2.92976923 |
| 148 | DNA-templated transcription, termination (GO:0006353) | 2.92799964 |
| 149 | mitotic sister chromatid segregation (GO:0000070) | 2.92202601 |
| 150 | mitotic spindle checkpoint (GO:0071174) | 2.91648034 |
| 151 | protein localization to mitochondrion (GO:0070585) | 2.89929482 |
| 152 | regulation of spindle organization (GO:0090224) | 2.89864997 |
| 153 | spindle checkpoint (GO:0031577) | 2.89850214 |
| 154 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 2.89146292 |
| 155 | sulfur amino acid metabolic process (GO:0000096) | 2.88667792 |
| 156 | 7-methylguanosine mRNA capping (GO:0006370) | 2.87144961 |
| 157 | urea cycle (GO:0000050) | 2.86495137 |
| 158 | urea metabolic process (GO:0019627) | 2.86495137 |
| 159 | negative regulation of mitotic sister chromatid segregation (GO:0033048) | 2.86484163 |
| 160 | negative regulation of sister chromatid segregation (GO:0033046) | 2.86484163 |
| 161 | drug catabolic process (GO:0042737) | 2.86177683 |
| 162 | ethanol oxidation (GO:0006069) | 2.84943512 |
| 163 | pantothenate metabolic process (GO:0015939) | 2.82149478 |
| 164 | metaphase plate congression (GO:0051310) | 2.82138051 |
| 165 | organic acid catabolic process (GO:0016054) | 2.80808493 |
| 166 | carboxylic acid catabolic process (GO:0046395) | 2.80808493 |
| 167 | acetyl-CoA metabolic process (GO:0006084) | 2.80766978 |
| 168 | fructose metabolic process (GO:0006000) | 2.76859439 |
| 169 | monocarboxylic acid catabolic process (GO:0072329) | 2.76509036 |
| 170 | coenzyme catabolic process (GO:0009109) | 2.75222622 |
| 171 | ubiquinone metabolic process (GO:0006743) | 2.74168509 |
| 172 | alpha-linolenic acid metabolic process (GO:0036109) | 2.73743580 |
| 173 | nucleoside salvage (GO:0043174) | 2.73018966 |
| 174 | carnitine transmembrane transport (GO:1902603) | 2.72862962 |
| 175 | sulfur amino acid biosynthetic process (GO:0000097) | 2.72240569 |
| 176 | triglyceride homeostasis (GO:0070328) | 2.71868268 |
| 177 | acylglycerol homeostasis (GO:0055090) | 2.71868268 |
| 178 | S-adenosylmethionine metabolic process (GO:0046500) | 2.69506004 |
| 179 | fatty acid homeostasis (GO:0055089) | 2.69402688 |
| 180 | NAD metabolic process (GO:0019674) | 2.68931981 |
| 181 | regulation of protein activation cascade (GO:2000257) | 2.68801924 |
| 182 | regulation of triglyceride catabolic process (GO:0010896) | 2.68583337 |
| 183 | one-carbon metabolic process (GO:0006730) | 2.68120702 |
| 184 | amino-acid betaine transport (GO:0015838) | 2.67899274 |
| 185 | carnitine transport (GO:0015879) | 2.67899274 |
| 186 | pyrimidine-containing compound transmembrane transport (GO:0072531) | 2.64688616 |
| 187 | oxidative phosphorylation (GO:0006119) | 2.64331545 |
| 188 | nitrogen cycle metabolic process (GO:0071941) | 2.63020180 |
| 189 | DNA deamination (GO:0045006) | 2.62930328 |
| 190 | ribosome assembly (GO:0042255) | 2.62383269 |
| 191 | L-methionine salvage (GO:0071267) | 2.59978608 |
| 192 | L-methionine biosynthetic process (GO:0071265) | 2.59978608 |
| 193 | amino acid salvage (GO:0043102) | 2.59978608 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 5.00539189 |
| 2 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.77664991 |
| 3 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.73422005 |
| 4 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.49525930 |
| 5 | * KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 3.44421128 |
| 6 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.18875869 |
| 7 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 3.16162035 |
| 8 | * MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.06015270 |
| 9 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.99597444 |
| 10 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.94397971 |
| 11 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.87648529 |
| 12 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.78054215 |
| 13 | * GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.76960116 |
| 14 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.73824319 |
| 15 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.69947952 |
| 16 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.56037094 |
| 17 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.55955101 |
| 18 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.46050899 |
| 19 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.43337480 |
| 20 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.34410872 |
| 21 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.25065989 |
| 22 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.23185393 |
| 23 | AR_21909140_ChIP-Seq_LNCAP_Human | 2.17319648 |
| 24 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.14007355 |
| 25 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.07705117 |
| 26 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.06554346 |
| 27 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.97303977 |
| 28 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.96112953 |
| 29 | GATA1_22025678_ChIP-Seq_K562_Human | 1.92483537 |
| 30 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.89438776 |
| 31 | * SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.86130632 |
| 32 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.79224921 |
| 33 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.76267369 |
| 34 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.75155902 |
| 35 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.74317623 |
| 36 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.72347603 |
| 37 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.71325097 |
| 38 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.68053983 |
| 39 | * GABP_19822575_ChIP-Seq_HepG2_Human | 1.67383628 |
| 40 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.66902557 |
| 41 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.65924763 |
| 42 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.58565624 |
| 43 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.57864124 |
| 44 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.57068251 |
| 45 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.56274370 |
| 46 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.55680669 |
| 47 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.54061876 |
| 48 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.53416522 |
| 49 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.51362206 |
| 50 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.50288774 |
| 51 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.49629927 |
| 52 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.49421497 |
| 53 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.49357018 |
| 54 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.42453461 |
| 55 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.42365075 |
| 56 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.38458677 |
| 57 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.37588996 |
| 58 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.37533682 |
| 59 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.35766425 |
| 60 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.34668260 |
| 61 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.32352524 |
| 62 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.32110973 |
| 63 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.29222921 |
| 64 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.28837161 |
| 65 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.27986100 |
| 66 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.27483952 |
| 67 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.26737202 |
| 68 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.26215419 |
| 69 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.26127414 |
| 70 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.23169043 |
| 71 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.21870109 |
| 72 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.21459502 |
| 73 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.21174787 |
| 74 | * THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.20131628 |
| 75 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 1.20125118 |
| 76 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.15853705 |
| 77 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.14865833 |
| 78 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.13969027 |
| 79 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.10783575 |
| 80 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.10169615 |
| 81 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.10130079 |
| 82 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.09885516 |
| 83 | MYC_22102868_ChIP-Seq_BL_Human | 1.07253102 |
| 84 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.06526713 |
| 85 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.05686976 |
| 86 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.04558978 |
| 87 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 1.04017390 |
| 88 | * POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.01405371 |
| 89 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.00924376 |
| 90 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 0.95614319 |
| 91 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 0.92950493 |
| 92 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.92500246 |
| 93 | * GATA4_21415370_ChIP-Seq_HL-1_Mouse | 0.90599546 |
| 94 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 0.90119481 |
| 95 | ELF5_23300383_ChIP-Seq_T47D_Human | 0.88949642 |
| 96 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.88290002 |
| 97 | TTF2_22483619_ChIP-Seq_HELA_Human | 0.86799721 |
| 98 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.85541615 |
| 99 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 0.84920854 |
| 100 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.82830705 |
| 101 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.82101658 |
| 102 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.80563105 |
| 103 | * E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 0.79779897 |
| 104 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.79749225 |
| 105 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.79689456 |
| 106 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 0.78774451 |
| 107 | * NANOG_16153702_ChIP-ChIP_HESCs_Human | 0.78449289 |
| 108 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 0.77264212 |
| 109 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.77181949 |
| 110 | CHD1_26751641_Chip-Seq_LNCaP_Human | 0.77050041 |
| 111 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.76991323 |
| 112 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.76941298 |
| 113 | * CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.76788128 |
| 114 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.76412520 |
| 115 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 0.75637429 |
| 116 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.75434270 |
| 117 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 0.74435838 |
| 118 | EWS_26573619_Chip-Seq_HEK293_Human | 0.73321156 |
| 119 | SOX2_19030024_ChIP-ChIP_MESCs_Mouse | 0.67423151 |
| 120 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 0.67414030 |
| 121 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 0.67414030 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 4.79164058 |
| 2 | MP0005365_abnormal_bile_salt | 4.55073566 |
| 3 | MP0005360_urolithiasis | 4.31600447 |
| 4 | MP0005085_abnormal_gallbladder_physiolo | 3.92725858 |
| 5 | MP0003806_abnormal_nucleotide_metabolis | 3.38295429 |
| 6 | MP0003646_muscle_fatigue | 3.24755458 |
| 7 | MP0008875_abnormal_xenobiotic_pharmacok | 3.24632831 |
| 8 | MP0003693_abnormal_embryo_hatching | 3.05492571 |
| 9 | MP0008932_abnormal_embryonic_tissue | 2.87767452 |
| 10 | MP0006036_abnormal_mitochondrial_physio | 2.59890448 |
| 11 | MP0003941_abnormal_skin_development | 2.33497280 |
| 12 | MP0002837_dystrophic_cardiac_calcinosis | 2.28060448 |
| 13 | MP0003252_abnormal_bile_duct | 2.22105642 |
| 14 | MP0005332_abnormal_amino_acid | 2.18717394 |
| 15 | MP0003656_abnormal_erythrocyte_physiolo | 2.12021168 |
| 16 | MP0004084_abnormal_cardiac_muscle | 2.10617630 |
| 17 | MP0009840_abnormal_foam_cell | 2.06747079 |
| 18 | MP0009697_abnormal_copulation | 2.05942842 |
| 19 | MP0010329_abnormal_lipoprotein_level | 2.02727697 |
| 20 | MP0003221_abnormal_cardiomyocyte_apopto | 1.85217386 |
| 21 | MP0010234_abnormal_vibrissa_follicle | 1.84749689 |
| 22 | MP0003186_abnormal_redox_activity | 1.75366567 |
| 23 | MP0004957_abnormal_blastocyst_morpholog | 1.73958519 |
| 24 | MP0005319_abnormal_enzyme/_coenzyme | 1.71980611 |
| 25 | MP0000609_abnormal_liver_physiology | 1.71491230 |
| 26 | MP0004130_abnormal_muscle_cell | 1.66375628 |
| 27 | MP0004036_abnormal_muscle_relaxation | 1.65327894 |
| 28 | MP0006035_abnormal_mitochondrial_morpho | 1.65307192 |
| 29 | MP0002396_abnormal_hematopoietic_system | 1.64353375 |
| 30 | MP0003195_calcinosis | 1.56006257 |
| 31 | MP0003077_abnormal_cell_cycle | 1.55388735 |
| 32 | MP0005330_cardiomyopathy | 1.54220484 |
| 33 | MP0001764_abnormal_homeostasis | 1.53965499 |
| 34 | MP0005451_abnormal_body_composition | 1.51794548 |
| 35 | MP0004215_abnormal_myocardial_fiber | 1.48563504 |
| 36 | MP0003111_abnormal_nucleus_morphology | 1.46214850 |
| 37 | MP0001666_abnormal_nutrient_absorption | 1.45769138 |
| 38 | MP0008877_abnormal_DNA_methylation | 1.44867928 |
| 39 | MP0002877_abnormal_melanocyte_morpholog | 1.43521656 |
| 40 | MP0004147_increased_porphyrin_level | 1.42507077 |
| 41 | MP0002080_prenatal_lethality | 1.41265385 |
| 42 | MP0010094_abnormal_chromosome_stability | 1.41147428 |
| 43 | MP0000749_muscle_degeneration | 1.40852069 |
| 44 | MP0000313_abnormal_cell_death | 1.39068262 |
| 45 | MP0005220_abnormal_exocrine_pancreas | 1.38801355 |
| 46 | MP0002118_abnormal_lipid_homeostasis | 1.37164171 |
| 47 | MP0010352_gastrointestinal_tract_polyps | 1.36462996 |
| 48 | MP0009643_abnormal_urine_homeostasis | 1.35206806 |
| 49 | MP0000750_abnormal_muscle_regeneration | 1.34662790 |
| 50 | MP0005083_abnormal_biliary_tract | 1.33246902 |
| 51 | MP0000372_irregular_coat_pigmentation | 1.33086540 |
| 52 | MP0003950_abnormal_plasma_membrane | 1.30763288 |
| 53 | MP0003718_maternal_effect | 1.25918330 |
| 54 | MP0002269_muscular_atrophy | 1.25121688 |
| 55 | MP0005670_abnormal_white_adipose | 1.22529650 |
| 56 | MP0008057_abnormal_DNA_replication | 1.21997108 |
| 57 | MP0002160_abnormal_reproductive_system | 1.14440441 |
| 58 | MP0004019_abnormal_vitamin_homeostasis | 1.14068227 |
| 59 | MP0000598_abnormal_liver_morphology | 1.13949953 |
| 60 | MP0001929_abnormal_gametogenesis | 1.11428465 |
| 61 | MP0002086_abnormal_extraembryonic_tissu | 1.10760823 |
| 62 | MP0003191_abnormal_cellular_cholesterol | 1.10062010 |
| 63 | MP0002019_abnormal_tumor_incidence | 1.08779267 |
| 64 | MP0000751_myopathy | 1.08668952 |
| 65 | MP0004087_abnormal_muscle_fiber | 1.07697422 |
| 66 | MP0000747_muscle_weakness | 1.07074019 |
| 67 | MP0005636_abnormal_mineral_homeostasis | 1.06093838 |
| 68 | MP0008007_abnormal_cellular_replicative | 1.04724814 |
| 69 | MP0005266_abnormal_metabolism | 1.04167561 |
| 70 | MP0002210_abnormal_sex_determination | 1.03692757 |
| 71 | MP0005385_cardiovascular_system_phenoty | 1.02615826 |
| 72 | MP0001544_abnormal_cardiovascular_syste | 1.02615826 |
| 73 | MP0002085_abnormal_embryonic_tissue | 1.01912175 |
| 74 | MP0001853_heart_inflammation | 1.01348840 |
| 75 | MP0002106_abnormal_muscle_physiology | 1.01266766 |
| 76 | MP0009672_abnormal_birth_weight | 1.01195135 |
| 77 | MP0004233_abnormal_muscle_weight | 1.00907725 |
| 78 | MP0003868_abnormal_feces_composition | 1.00357946 |
| 79 | MP0004043_abnormal_pH_regulation | 0.99921675 |
| 80 | MP0008995_early_reproductive_senescence | 0.99448083 |
| 81 | MP0005501_abnormal_skin_physiology | 0.99133442 |
| 82 | MP0010630_abnormal_cardiac_muscle | 0.97405571 |
| 83 | MP0002084_abnormal_developmental_patter | 0.97105020 |
| 84 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.96304093 |
| 85 | MP0001881_abnormal_mammary_gland | 0.95532961 |
| 86 | MP0002971_abnormal_brown_adipose | 0.95530768 |
| 87 | MP0005408_hypopigmentation | 0.94842358 |
| 88 | MP0002938_white_spotting | 0.94777094 |
| 89 | MP0002796_impaired_skin_barrier | 0.93827986 |
| 90 | MP0003890_abnormal_embryonic-extraembry | 0.93575559 |
| 91 | MP0001661_extended_life_span | 0.92085526 |
| 92 | MP0005666_abnormal_adipose_tissue | 0.91220910 |
| 93 | MP0001730_embryonic_growth_arrest | 0.90866112 |
| 94 | MP0001145_abnormal_male_reproductive | 0.88976892 |
| 95 | MP0005620_abnormal_muscle_contractility | 0.88928847 |
| 96 | MP0005395_other_phenotype | 0.87956807 |
| 97 | MP0004484_altered_response_of | 0.87571898 |
| 98 | MP0001756_abnormal_urination | 0.87195160 |
| 99 | MP0009333_abnormal_splenocyte_physiolog | 0.85510743 |
| 100 | MP0001545_abnormal_hematopoietic_system | 0.85508335 |
| 101 | MP0005397_hematopoietic_system_phenotyp | 0.85508335 |
| 102 | MP0005384_cellular_phenotype | 0.85087721 |
| 103 | MP0008058_abnormal_DNA_repair | 0.84560744 |
| 104 | MP0000653_abnormal_sex_gland | 0.84408696 |
| 105 | MP0003567_abnormal_fetal_cardiomyocyte | 0.84304739 |
| 106 | MP0004264_abnormal_extraembryonic_tissu | 0.84021454 |
| 107 | MP0002078_abnormal_glucose_homeostasis | 0.83672154 |
| 108 | MP0003943_abnormal_hepatobiliary_system | 0.82797928 |
| 109 | MP0003984_embryonic_growth_retardation | 0.82729200 |
| 110 | MP0002138_abnormal_hepatobiliary_system | 0.82672907 |
| 111 | MP0005084_abnormal_gallbladder_morpholo | 0.81274526 |
| 112 | MP0002060_abnormal_skin_morphology | 0.81074125 |
| 113 | MP0002972_abnormal_cardiac_muscle | 0.79997968 |
| 114 | MP0002088_abnormal_embryonic_growth/wei | 0.79761722 |
| 115 | MP0000490_abnormal_crypts_of | 0.79694122 |
| 116 | MP0001672_abnormal_embryogenesis/_devel | 0.79386382 |
| 117 | MP0005380_embryogenesis_phenotype | 0.79386382 |
| 118 | MP0004197_abnormal_fetal_growth/weight/ | 0.77807106 |
| 119 | MP0006138_congestive_heart_failure | 0.77615927 |
| 120 | MP0000627_abnormal_mammary_gland | 0.76656329 |
| 121 | MP0005376_homeostasis/metabolism_phenot | 0.76429411 |
| 122 | MP0003315_abnormal_perineum_morphology | 0.75808787 |
| 123 | MP0004185_abnormal_adipocyte_glucose | 0.75290527 |
| 124 | MP0004808_abnormal_hematopoietic_stem | 0.74763636 |
| 125 | MP0001216_abnormal_epidermal_layer | 0.74570297 |
| 126 | MP0005075_abnormal_melanosome_morpholog | 0.74519825 |
| 127 | MP0001119_abnormal_female_reproductive | 0.74461862 |
| 128 | MP0005369_muscle_phenotype | 0.73770592 |
| 129 | MP0003828_pulmonary_edema | 0.71988850 |
| 130 | MP0010307_abnormal_tumor_latency | 0.70649460 |
| 131 | MP0009703_decreased_birth_body | 0.70159208 |
| 132 | MP0005621_abnormal_cell_physiology | 0.69538694 |
| 133 | MP0002006_tumorigenesis | 0.68366349 |
| 134 | MP0001697_abnormal_embryo_size | 0.68261880 |
| 135 | MP0005334_abnormal_fat_pad | 0.67646025 |
| 136 | MP0000350_abnormal_cell_proliferation | 0.66927937 |
| 137 | MP0003786_premature_aging | 0.66449159 |
| 138 | MP0000343_altered_response_to | 0.66444909 |
| 139 | MP0005379_endocrine/exocrine_gland_phen | 0.64928281 |
| 140 | MP0008469_abnormal_protein_level | 0.64795103 |
| 141 | MP0009763_increased_sensitivity_to | 0.63948009 |
| 142 | MP0009642_abnormal_blood_homeostasis | 0.63933541 |
| 143 | MP0008873_increased_physiological_sensi | 0.62796038 |
| 144 | MP0000358_abnormal_cell_content/ | 0.62377064 |
| 145 | MP0003699_abnormal_female_reproductive | 0.62341885 |
| 146 | MP0005647_abnormal_sex_gland | 0.61868816 |
| 147 | MP0005389_reproductive_system_phenotype | 0.60621561 |
| 148 | MP0000516_abnormal_urinary_system | 0.59419280 |
| 149 | MP0005367_renal/urinary_system_phenotyp | 0.59419280 |
| 150 | MP0005410_abnormal_fertilization | 0.58996323 |
| 151 | MP0000703_abnormal_thymus_morphology | 0.58583815 |
| 152 | MP0002163_abnormal_gland_morphology | 0.57938731 |
| 153 | MP0006072_abnormal_retinal_apoptosis | 0.57368018 |
| 154 | MP0001727_abnormal_embryo_implantation | 0.56960259 |
| 155 | MP0001529_abnormal_vocalization | 0.54273697 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hyperglycinemia (HP:0002154) | 5.21838875 |
| 2 | Hyperglycinuria (HP:0003108) | 5.11915191 |
| 3 | Abnormality of glycine metabolism (HP:0010895) | 4.50289802 |
| 4 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.50289802 |
| 5 | Hypoglycemic coma (HP:0001325) | 4.27992773 |
| 6 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.89211591 |
| 7 | Abnormality of serum amino acid levels (HP:0003112) | 3.89206470 |
| 8 | Hyperammonemia (HP:0001987) | 3.87224973 |
| 9 | Gout (HP:0001997) | 3.73037978 |
| 10 | Microvesicular hepatic steatosis (HP:0001414) | 3.73032490 |
| 11 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.55498954 |
| 12 | Increased hepatocellular lipid droplets (HP:0006565) | 3.55064108 |
| 13 | Hyperalaninemia (HP:0003348) | 3.54654053 |
| 14 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 3.54654053 |
| 15 | Abnormality of alanine metabolism (HP:0010916) | 3.54654053 |
| 16 | Dicarboxylic aciduria (HP:0003215) | 3.54419843 |
| 17 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 3.54419843 |
| 18 | Intrahepatic cholestasis (HP:0001406) | 3.49218813 |
| 19 | Ketosis (HP:0001946) | 3.45644897 |
| 20 | Rhabdomyolysis (HP:0003201) | 3.43864675 |
| 21 | Chromsome breakage (HP:0040012) | 3.39306608 |
| 22 | Hypobetalipoproteinemia (HP:0003563) | 3.36488224 |
| 23 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 3.36122336 |
| 24 | Type I transferrin isoform profile (HP:0003642) | 3.34990751 |
| 25 | Hepatic necrosis (HP:0002605) | 3.28354859 |
| 26 | Degeneration of anterior horn cells (HP:0002398) | 3.25399206 |
| 27 | Abnormality of the anterior horn cell (HP:0006802) | 3.25399206 |
| 28 | Myoglobinuria (HP:0002913) | 3.22368420 |
| 29 | Aplastic anemia (HP:0001915) | 3.17616799 |
| 30 | Ketoacidosis (HP:0001993) | 3.10885674 |
| 31 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.09453910 |
| 32 | Lipid accumulation in hepatocytes (HP:0006561) | 3.07824202 |
| 33 | Reduced antithrombin III activity (HP:0001976) | 3.05077169 |
| 34 | Progressive macrocephaly (HP:0004481) | 3.02256636 |
| 35 | Proximal tubulopathy (HP:0000114) | 3.02102283 |
| 36 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.99854331 |
| 37 | Generalized aminoaciduria (HP:0002909) | 2.97610290 |
| 38 | Lethargy (HP:0001254) | 2.96452741 |
| 39 | Muscle fiber splitting (HP:0003555) | 2.88429207 |
| 40 | Hyperglycemia (HP:0003074) | 2.86203364 |
| 41 | Abnormality of the preputium (HP:0100587) | 2.85725579 |
| 42 | Cerebral edema (HP:0002181) | 2.81731058 |
| 43 | Metabolic acidosis (HP:0001942) | 2.77873382 |
| 44 | Hyperuricemia (HP:0002149) | 2.77698249 |
| 45 | Increased purine levels (HP:0004368) | 2.77698249 |
| 46 | Exercise-induced muscle cramps (HP:0003710) | 2.77671672 |
| 47 | Hypolipoproteinemia (HP:0010981) | 2.70389652 |
| 48 | Lactic acidosis (HP:0003128) | 2.69334650 |
| 49 | Abnormality of glycolysis (HP:0004366) | 2.66659161 |
| 50 | Increased serum pyruvate (HP:0003542) | 2.66659161 |
| 51 | Deep venous thrombosis (HP:0002625) | 2.65700009 |
| 52 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.64761630 |
| 53 | Abnormality of purine metabolism (HP:0004352) | 2.64504178 |
| 54 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.63080561 |
| 55 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.63080561 |
| 56 | Abnormal protein glycosylation (HP:0012346) | 2.63080561 |
| 57 | Abnormal glycosylation (HP:0012345) | 2.63080561 |
| 58 | Xanthomatosis (HP:0000991) | 2.62970833 |
| 59 | Ragged-red muscle fibers (HP:0003200) | 2.62932854 |
| 60 | Nausea (HP:0002018) | 2.60683123 |
| 61 | Pancytopenia (HP:0001876) | 2.58381837 |
| 62 | Hyperlipoproteinemia (HP:0010980) | 2.58229789 |
| 63 | Increased intramyocellular lipid droplets (HP:0012240) | 2.57412717 |
| 64 | Exercise-induced myalgia (HP:0003738) | 2.56395818 |
| 65 | Abnormality of chromosome stability (HP:0003220) | 2.55815399 |
| 66 | Hepatocellular necrosis (HP:0001404) | 2.55378024 |
| 67 | Acute encephalopathy (HP:0006846) | 2.55038099 |
| 68 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.54603428 |
| 69 | Renal cortical cysts (HP:0000803) | 2.52587118 |
| 70 | Multiple enchondromatosis (HP:0005701) | 2.52005029 |
| 71 | Abnormality of the intrinsic pathway (HP:0010989) | 2.49227286 |
| 72 | Exercise intolerance (HP:0003546) | 2.47213094 |
| 73 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.46594106 |
| 74 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.46594106 |
| 75 | Rough bone trabeculation (HP:0100670) | 2.44788451 |
| 76 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.43889230 |
| 77 | Abnormality of methionine metabolism (HP:0010901) | 2.43467703 |
| 78 | Meckel diverticulum (HP:0002245) | 2.42575865 |
| 79 | Renal Fanconi syndrome (HP:0001994) | 2.42251529 |
| 80 | Impaired proprioception (HP:0010831) | 2.42115011 |
| 81 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.40378318 |
| 82 | Hypoalphalipoproteinemia (HP:0003233) | 2.40143316 |
| 83 | Abnormality of nucleobase metabolism (HP:0010932) | 2.38114798 |
| 84 | Methylmalonic acidemia (HP:0002912) | 2.34994574 |
| 85 | Palpitations (HP:0001962) | 2.34445110 |
| 86 | Increased CSF lactate (HP:0002490) | 2.33739978 |
| 87 | Fat malabsorption (HP:0002630) | 2.32162653 |
| 88 | Increased serum lactate (HP:0002151) | 2.29827464 |
| 89 | Oral leukoplakia (HP:0002745) | 2.26777445 |
| 90 | Birth length less than 3rd percentile (HP:0003561) | 2.25929296 |
| 91 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 2.25829532 |
| 92 | Myelodysplasia (HP:0002863) | 2.24383792 |
| 93 | Abnormal cartilage morphology (HP:0002763) | 2.23911418 |
| 94 | Limb hypertonia (HP:0002509) | 2.23409652 |
| 95 | Abnormality of the ileum (HP:0001549) | 2.22619546 |
| 96 | Small intestinal stenosis (HP:0012848) | 2.22301848 |
| 97 | Duodenal stenosis (HP:0100867) | 2.22301848 |
| 98 | Premature ovarian failure (HP:0008209) | 2.21515695 |
| 99 | CNS demyelination (HP:0007305) | 2.20152958 |
| 100 | Atrioventricular block (HP:0001678) | 2.19723715 |
| 101 | Sparse eyelashes (HP:0000653) | 2.16414452 |
| 102 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.15971121 |
| 103 | Megaloblastic anemia (HP:0001889) | 2.14325704 |
| 104 | Increased muscle lipid content (HP:0009058) | 2.13016617 |
| 105 | Trismus (HP:0000211) | 2.12174879 |
| 106 | 3-Methylglutaconic aciduria (HP:0003535) | 2.10955134 |
| 107 | Progressive external ophthalmoplegia (HP:0000590) | 2.08747838 |
| 108 | Sensory axonal neuropathy (HP:0003390) | 2.06945250 |
| 109 | Abnormality of lateral ventricle (HP:0030047) | 2.05378541 |
| 110 | Hyperbilirubinemia (HP:0002904) | 2.04397487 |
| 111 | Muscle fiber inclusion bodies (HP:0100299) | 2.04266594 |
| 112 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.02660422 |
| 113 | Progressive muscle weakness (HP:0003323) | 2.02266020 |
| 114 | Neoplasm of the adrenal gland (HP:0100631) | 2.01963424 |
| 115 | Bundle branch block (HP:0011710) | 2.01350404 |
| 116 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.00797229 |
| 117 | Abnormal lung lobation (HP:0002101) | 1.99933072 |
| 118 | Secondary amenorrhea (HP:0000869) | 1.99336895 |
| 119 | Abnormal spermatogenesis (HP:0008669) | 1.99300867 |
| 120 | Methylmalonic aciduria (HP:0012120) | 1.98606807 |
| 121 | Respiratory difficulties (HP:0002880) | 1.97947370 |
| 122 | Abnormality of the common coagulation pathway (HP:0010990) | 1.97860293 |
| 123 | Cutaneous melanoma (HP:0012056) | 1.96450902 |
| 124 | Abnormal mitochondria in muscle tissue (HP:0008316) | 1.96203948 |
| 125 | Vomiting (HP:0002013) | 1.96067210 |
| 126 | Spastic paraparesis (HP:0002313) | 1.95096879 |
| 127 | Calf muscle hypertrophy (HP:0008981) | 1.94864459 |
| 128 | Carpal bone hypoplasia (HP:0001498) | 1.94051652 |
| 129 | Prolonged partial thromboplastin time (HP:0003645) | 1.92695032 |
| 130 | Hypokinesia (HP:0002375) | 1.92627408 |
| 131 | Macrocytic anemia (HP:0001972) | 1.92037208 |
| 132 | Abnormal trabecular bone morphology (HP:0100671) | 1.92021551 |
| 133 | Steatorrhea (HP:0002570) | 1.91815352 |
| 134 | Nemaline bodies (HP:0003798) | 1.91154092 |
| 135 | Abnormality of urine glucose concentration (HP:0011016) | 1.90304473 |
| 136 | Glycosuria (HP:0003076) | 1.90304473 |
| 137 | Insulin-resistant diabetes mellitus (HP:0000831) | 1.90021570 |
| 138 | Nephroblastoma (Wilms tumor) (HP:0002667) | 1.89708874 |
| 139 | Ileus (HP:0002595) | 1.87291192 |
| 140 | Lipoatrophy (HP:0100578) | 1.86612816 |
| 141 | Mitochondrial inheritance (HP:0001427) | 1.86395632 |
| 142 | Amniotic constriction ring (HP:0009775) | 1.85631238 |
| 143 | Abnormality of placental membranes (HP:0011409) | 1.85631238 |
| 144 | Abnormality of the duodenum (HP:0002246) | 1.85491587 |
| 145 | Abnormality of pyrimidine metabolism (HP:0004353) | 1.85336036 |
| 146 | Abnormality of the umbilical cord (HP:0010881) | 1.85054222 |
| 147 | Hepatocellular carcinoma (HP:0001402) | 1.84969797 |
| 148 | Irregular epiphyses (HP:0010582) | 1.84932986 |
| 149 | Entropion (HP:0000621) | 1.84563092 |
| 150 | Acute necrotizing encephalopathy (HP:0006965) | 1.83882676 |
| 151 | Respiratory failure (HP:0002878) | 1.83823040 |
| 152 | Reduced subcutaneous adipose tissue (HP:0003758) | 1.82674873 |
| 153 | Homocystinuria (HP:0002156) | 1.82028573 |
| 154 | Abnormality of homocysteine metabolism (HP:0010919) | 1.82028573 |
| 155 | Squamous cell carcinoma (HP:0002860) | 1.80474210 |
| 156 | Overlapping toe (HP:0001845) | 1.80436897 |
| 157 | Ventricular tachycardia (HP:0004756) | 1.80187387 |
| 158 | Abnormalities of placenta or umbilical cord (HP:0001194) | 1.79736024 |
| 159 | Conjunctival hamartoma (HP:0100780) | 1.76144432 |
| 160 | Horseshoe kidney (HP:0000085) | 1.76014171 |
| 161 | Absent thumb (HP:0009777) | 1.75158899 |
| 162 | Embryonal renal neoplasm (HP:0011794) | 1.73787604 |
| 163 | Leukodystrophy (HP:0002415) | 1.70396132 |
| 164 | Fatigue (HP:0012378) | 1.69493082 |
| 165 | Postnatal microcephaly (HP:0005484) | 1.69101862 |
| 166 | Hypergonadotropic hypogonadism (HP:0000815) | 1.68119595 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NEK1 | 4.93142943 |
| 2 | BCKDK | 4.49927546 |
| 3 | MST4 | 4.00764902 |
| 4 | EIF2AK1 | 3.72712693 |
| 5 | PBK | 3.23207477 |
| 6 | BUB1 | 2.65271143 |
| 7 | PDK4 | 2.61596600 |
| 8 | PDK3 | 2.61596600 |
| 9 | NEK2 | 2.60574263 |
| 10 | STK38L | 2.49553624 |
| 11 | BRSK2 | 2.44747141 |
| 12 | VRK2 | 2.28225630 |
| 13 | LATS1 | 2.15782150 |
| 14 | PDK2 | 2.14678117 |
| 15 | SCYL2 | 2.06291296 |
| 16 | WEE1 | 2.05784949 |
| 17 | FRK | 1.92018110 |
| 18 | PINK1 | 1.79585885 |
| 19 | MAP3K3 | 1.79239113 |
| 20 | EIF2AK3 | 1.77487038 |
| 21 | NEK9 | 1.76513834 |
| 22 | TAF1 | 1.73881246 |
| 23 | LMTK2 | 1.71077433 |
| 24 | ACVR1B | 1.66795265 |
| 25 | TTN | 1.60425192 |
| 26 | OBSCN | 1.49510480 |
| 27 | PLK4 | 1.48930915 |
| 28 | MAP2K3 | 1.42788506 |
| 29 | STK24 | 1.37541998 |
| 30 | NME2 | 1.37511360 |
| 31 | ZAK | 1.30606475 |
| 32 | TTK | 1.29464878 |
| 33 | PKN2 | 1.27797558 |
| 34 | DYRK3 | 1.27633499 |
| 35 | BRSK1 | 1.24197068 |
| 36 | MAP3K12 | 1.23720199 |
| 37 | FLT3 | 1.21807391 |
| 38 | MAP3K5 | 1.17328488 |
| 39 | EIF2AK2 | 1.17139285 |
| 40 | TRIM28 | 1.14955167 |
| 41 | ERN1 | 1.14711504 |
| 42 | IRAK3 | 1.12415320 |
| 43 | LATS2 | 1.11507851 |
| 44 | NUAK1 | 1.11263835 |
| 45 | PAK4 | 1.07482251 |
| 46 | CCNB1 | 1.06909012 |
| 47 | SRPK1 | 1.06464324 |
| 48 | AKT3 | 1.03808072 |
| 49 | STK16 | 1.02865608 |
| 50 | MST1R | 1.02050127 |
| 51 | PLK3 | 1.01998579 |
| 52 | AURKB | 1.01615290 |
| 53 | PLK1 | 0.98275083 |
| 54 | ERBB3 | 0.98263830 |
| 55 | INSRR | 0.96617970 |
| 56 | PRKAA1 | 0.95116419 |
| 57 | CDK8 | 0.94963534 |
| 58 | SIK1 | 0.93868144 |
| 59 | TRIB3 | 0.92692982 |
| 60 | ALK | 0.90078741 |
| 61 | PASK | 0.88451742 |
| 62 | RPS6KA4 | 0.86967079 |
| 63 | CDK4 | 0.86531942 |
| 64 | MYLK | 0.85577103 |
| 65 | FGFR4 | 0.84657154 |
| 66 | RAF1 | 0.84562232 |
| 67 | BCR | 0.83607374 |
| 68 | CDC7 | 0.83062030 |
| 69 | MAPK11 | 0.80839049 |
| 70 | STK3 | 0.80154227 |
| 71 | MAP3K6 | 0.79810543 |
| 72 | MKNK2 | 0.78656215 |
| 73 | CDK6 | 0.78544155 |
| 74 | ZAP70 | 0.75446281 |
| 75 | AURKA | 0.74557299 |
| 76 | TAOK1 | 0.74489977 |
| 77 | TAOK3 | 0.71654462 |
| 78 | MAP3K8 | 0.71406983 |
| 79 | BRAF | 0.71372410 |
| 80 | CHEK2 | 0.68859368 |
| 81 | PIK3CG | 0.68629251 |
| 82 | NME1 | 0.67839631 |
| 83 | ATM | 0.64613830 |
| 84 | CSNK2A2 | 0.64010389 |
| 85 | PRKAA2 | 0.62169294 |
| 86 | ERBB4 | 0.59729835 |
| 87 | ABL2 | 0.59111903 |
| 88 | FGFR3 | 0.58992319 |
| 89 | STK10 | 0.58383924 |
| 90 | CDK9 | 0.57722378 |
| 91 | MAP3K11 | 0.56872504 |
| 92 | BMPR2 | 0.56180019 |
| 93 | PIM2 | 0.55910539 |
| 94 | CAMKK2 | 0.55105826 |
| 95 | PRKCI | 0.53710496 |
| 96 | ATR | 0.51622536 |
| 97 | MAP4K1 | 0.50968418 |
| 98 | MET | 0.49491877 |
| 99 | MAPKAPK3 | 0.48623040 |
| 100 | EPHA2 | 0.48463048 |
| 101 | ARAF | 0.48393761 |
| 102 | MKNK1 | 0.47980504 |
| 103 | JAK1 | 0.47316623 |
| 104 | TSSK6 | 0.46664050 |
| 105 | SGK2 | 0.46229261 |
| 106 | PIM1 | 0.46093382 |
| 107 | STK4 | 0.45417437 |
| 108 | CLK1 | 0.44579785 |
| 109 | MARK3 | 0.43980099 |
| 110 | MAPK4 | 0.42735380 |
| 111 | TYK2 | 0.42577289 |
| 112 | LIMK1 | 0.41670987 |
| 113 | PIK3CA | 0.41031489 |
| 114 | MAP2K4 | 0.40965209 |
| 115 | MUSK | 0.40889220 |
| 116 | CDK1 | 0.40839568 |
| 117 | PRKG2 | 0.39669632 |
| 118 | CHEK1 | 0.38847669 |
| 119 | CDK7 | 0.37731152 |
| 120 | DAPK1 | 0.37290483 |
| 121 | CSNK1E | 0.36888104 |
| 122 | CDK2 | 0.36819860 |
| 123 | VRK1 | 0.36402736 |
| 124 | TEC | 0.35431078 |
| 125 | AKT2 | 0.33844783 |
| 126 | SIK3 | 0.33821249 |
| 127 | RPS6KA5 | 0.33707209 |
| 128 | PAK1 | 0.32778221 |
| 129 | TAOK2 | 0.32488366 |
| 130 | MAP3K9 | 0.31985037 |
| 131 | TNIK | 0.31851424 |
| 132 | MAPK12 | 0.31469437 |
| 133 | SGK3 | 0.31236945 |
| 134 | WNK3 | 0.30952018 |
| 135 | NEK6 | 0.30676408 |
| 136 | MELK | 0.29717593 |
| 137 | KDR | 0.29565339 |
| 138 | CDK3 | 0.28570120 |
| 139 | CSNK2A1 | 0.28053619 |
| 140 | CSNK1G1 | 0.27999133 |
| 141 | RPS6KB2 | 0.27989623 |
| 142 | BMPR1B | 0.27475550 |
| 143 | PAK2 | 0.26397247 |
| 144 | FGFR1 | 0.21616249 |
| 145 | PLK2 | 0.19616470 |
| 146 | TESK1 | 0.18526922 |
| 147 | CSNK1G3 | 0.18466447 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 3.31007539 |
| 2 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 3.14607392 |
| 3 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.95932310 |
| 4 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.88408473 |
| 5 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.84864837 |
| 6 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.69073337 |
| 7 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 2.62308303 |
| 8 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.61608292 |
| 9 | Ribosome_Homo sapiens_hsa03010 | 2.48463812 |
| 10 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.47689478 |
| 11 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.14343299 |
| 12 | Carbon metabolism_Homo sapiens_hsa01200 | 2.14085054 |
| 13 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.08490181 |
| 14 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.98338230 |
| 15 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.89821924 |
| 16 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.88485485 |
| 17 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.87085552 |
| 18 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.85598147 |
| 19 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.83031672 |
| 20 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.78676271 |
| 21 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.76705554 |
| 22 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.75345162 |
| 23 | Peroxisome_Homo sapiens_hsa04146 | 1.70753154 |
| 24 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.70642947 |
| 25 | RNA polymerase_Homo sapiens_hsa03020 | 1.65953220 |
| 26 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.62666028 |
| 27 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.61571161 |
| 28 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.58391982 |
| 29 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.57511384 |
| 30 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.56101639 |
| 31 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.53752072 |
| 32 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.46800743 |
| 33 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.45940714 |
| 34 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.38743868 |
| 35 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.37804442 |
| 36 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.35498854 |
| 37 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.33503430 |
| 38 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.33223409 |
| 39 | Proteasome_Homo sapiens_hsa03050 | 1.30739003 |
| 40 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 1.28831669 |
| 41 | Sulfur relay system_Homo sapiens_hsa04122 | 1.28477435 |
| 42 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.27995931 |
| 43 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.24481420 |
| 44 | RNA transport_Homo sapiens_hsa03013 | 1.23967455 |
| 45 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.21283983 |
| 46 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.11325617 |
| 47 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.11095639 |
| 48 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.09906478 |
| 49 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.09333776 |
| 50 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.04580300 |
| 51 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.04472588 |
| 52 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.99083746 |
| 53 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.98613369 |
| 54 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.96864034 |
| 55 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.96409916 |
| 56 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.90215981 |
| 57 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.89961746 |
| 58 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.89125990 |
| 59 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.88726372 |
| 60 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.87784333 |
| 61 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.86216780 |
| 62 | Cell cycle_Homo sapiens_hsa04110 | 0.84890028 |
| 63 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.82588345 |
| 64 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.82265339 |
| 65 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.81805591 |
| 66 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.81305754 |
| 67 | Retinol metabolism_Homo sapiens_hsa00830 | 0.79173161 |
| 68 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.78118161 |
| 69 | DNA replication_Homo sapiens_hsa03030 | 0.77808435 |
| 70 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.77113666 |
| 71 | RNA degradation_Homo sapiens_hsa03018 | 0.76838108 |
| 72 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.75708927 |
| 73 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.74994052 |
| 74 | Parkinsons disease_Homo sapiens_hsa05012 | 0.74797857 |
| 75 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.74089958 |
| 76 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.73326494 |
| 77 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.71735113 |
| 78 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.69943205 |
| 79 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.69737711 |
| 80 | Metabolic pathways_Homo sapiens_hsa01100 | 0.69692765 |
| 81 | Purine metabolism_Homo sapiens_hsa00230 | 0.66906113 |
| 82 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.66613668 |
| 83 | Galactose metabolism_Homo sapiens_hsa00052 | 0.65416354 |
| 84 | Lysine degradation_Homo sapiens_hsa00310 | 0.64340207 |
| 85 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.62801026 |
| 86 | Base excision repair_Homo sapiens_hsa03410 | 0.61630251 |
| 87 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.60125180 |
| 88 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.59883459 |
| 89 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.58909651 |
| 90 | Basal transcription factors_Homo sapiens_hsa03022 | 0.58677363 |
| 91 | Bile secretion_Homo sapiens_hsa04976 | 0.53142406 |
| 92 | Histidine metabolism_Homo sapiens_hsa00340 | 0.52792771 |
| 93 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.51790563 |
| 94 | Protein export_Homo sapiens_hsa03060 | 0.50968049 |
| 95 | Legionellosis_Homo sapiens_hsa05134 | 0.50256950 |
| 96 | Huntingtons disease_Homo sapiens_hsa05016 | 0.50082991 |
| 97 | ABC transporters_Homo sapiens_hsa02010 | 0.49698492 |
| 98 | Mismatch repair_Homo sapiens_hsa03430 | 0.49660817 |
| 99 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.47789313 |
| 100 | Spliceosome_Homo sapiens_hsa03040 | 0.47569896 |
| 101 | Insulin resistance_Homo sapiens_hsa04931 | 0.47401100 |
| 102 | Circadian rhythm_Homo sapiens_hsa04710 | 0.46161869 |
| 103 | Homologous recombination_Homo sapiens_hsa03440 | 0.44469046 |
| 104 | Thyroid cancer_Homo sapiens_hsa05216 | 0.43348876 |
| 105 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.41770915 |
| 106 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.35629496 |
| 107 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.32049152 |
| 108 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.31434304 |
| 109 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.30724004 |
| 110 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.29727677 |
| 111 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.29680064 |
| 112 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.29579179 |
| 113 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.22819624 |
| 114 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.21602944 |
| 115 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.21374652 |
| 116 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.20771082 |
| 117 | Alzheimers disease_Homo sapiens_hsa05010 | 0.20564838 |
| 118 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.20552435 |
| 119 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.16157893 |
| 120 | Shigellosis_Homo sapiens_hsa05131 | 0.12846815 |
| 121 | Alcoholism_Homo sapiens_hsa05034 | 0.09384496 |
| 122 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.07211610 |
| 123 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.07153205 |

